Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization

Development Growth and Differentiation

Volumn 56, Issue 4, 2014, Pages 255-275

  Kaenel, Philip ^a   Hahnewald, Stefan ^a   Wotzkow, Carlos ^a   Strange, Robert ^a   Andres, Anne Catherine ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Ductal outgrowths; Luminal epithelial cells; Repopulation assay; Stem cells; Wnt signaling

Indexed keywords

ALPHA6 INTEGRIN; CD24 ANTIGEN; CELL SURFACE MARKER; EPHRIN RECEPTOR B4; EPHB4 PROTEIN, MOUSE;

ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRANCHING MORPHOGENESIS; BREAST EPITHELIUM; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FATE; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL TRANSPLANTATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC CELL; INTRACELLULAR SIGNALING; MAMMARY GLAND; MOUSE; NONHUMAN; REGENERATIVE ABILITY; SIGNAL TRANSDUCTION; STEM CELL; STROMA CELL; VASCULARIZATION; WNT SIGNALING PATHWAY; ANIMAL; CYTOLOGY; EPITHELIUM; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UDDER;

ANIMALS; CELL DIFFERENTIATION; EPITHELIAL CELLS; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; RECEPTOR, EPHB4; STEM CELLS;

EID: 84899545017     PISSN: 00121592     EISSN: 1440169X     Source Type: Journal    
DOI: 10.1111/dgd.12126     Document Type: Article

References (78)

1. Adams, R. H. 2002. Vascular patterning by Eph receptor tyrosine kinases and ephrins. Semin. Cell Dev. Biol. 13, 55-60.
2. Anderson, L. H., Boulanger, C. A., Smith, G. H., Carmeliet, P. & Watson, C. J. 2011. Stem cell marker prominin-1 regulates branching morphogenesis, but not regenerative capacity, in the mammary gland. Dev. Dyn. 240, 674-681.
3. Andres, A. C. & Djonov, V. 2010. The mammary gland vasculature revisited. J. Mammary Gland Biol. Neoplasia 15, 319-328.
4. Arend, W. P., Malyak, M., Guthridge, C. J. & Gabay, C. 1998. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16, 27-55.
5. Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M.M., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T. & Clevers, H. 2002. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111, 251-263.
6. Betterman, K. L., Paquet-Fifield, S., Asselin-Labat, M. L., Visvader, J.E., Butler, L.M., Stacker, S.A., Achen, M.G. & Harvey, N.L. 2012. Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli. Am. J. Pathol. 181, 2225-2238.
7. Bradbury, J. M., Edwards, P. A., Niemeyer, C. C. & Dale, T. C. 1995. Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev. Biol. 170, 553-563.
8. Brisken, C. & Duss, S. 2007. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev. 3, 147-156.
9. Bush, J. O. & Soriano, P. 2012. Eph/ephrin signaling: genetic, phosphoproteomic, and transcriptomic approaches. Semin. Cell Dev. Biol. 23, 26-34.
10. Cheng, N., Brantley, D. M. & Chen, J. 2002. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev. 13, 75-85.
11. Cohn, E., Ossowski, L., Bertran, S., Marzan, C. & Farias, E. F. 2010. RARalpha1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis. Breast Cancer Res. 12, R79.
12. DeOme, K. B., Faulkin, L. J. Jr, Bern, H. A. & Blair, P. B. 1959. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res. 19, 515-520.
13. Dulbecco, R., Henahan, M. & Armstrong, B. 1982. Cell types and morphogenesis in the mammary gland. Proc. Natl Acad. Sci. USA 79, 7346-7350.
14. Ebnet, K., Aurrand-Lions, M., Kuhn, A., Kiefer, F., Butz, S., Zander, K., Meyer zu Brickwedde, M.K., Suzuki, A., Imhof, B.A. & Vestweber, D. 2003. The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: a possible role for JAMs in endothelial cell polarity. J. Cell Sci. 116, 3879-3891.
15. Egawa, M., Yoshioka, S., Higuchi, T., Sato, Y., Tatsumi, K., Fujiwara, H. & Fujii, S. 2003. Ephrin B1 is expressed on human luteinizing granulosa cells in corpora lutea of the early luteal phase: the possible involvement of the B class Eph-ephrin system during corpus luteum formation. J. Clin. Endocrinol. Metab. 88, 4384-4392.
16. Fata, J. E., Werb, Z. & Bissell, M. J. 2004. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res. 6, 1-11.
17. Forsman, C. L., Ng, B. C., Heinze, R. K., Kuo, C., Sergi, C., Gopalakrishnan, R., Yee, D., Graf, D., Schwertfeger, K.L. & Petryk, A. 2013. BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization. Dev. Biol. 373, 95-106.
18. Gastaldi, S., Sassi, F., Accornero, P., Torti, D., Galimi, F., Migliardi, G., Molyneux, G., Perera, T., Comoglio, P.M., Boccaccio, C., Smalley, M.J., Bertotti, A. & Trusolino, L. 2013. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. Oncogene 32, 1428-1440.
19. Gauger, K. J., Shimono, A., Crisi, G. M. & Schneider, S. S. 2012. Loss of SFRP1 promotes ductal branching in the murine mammary gland. BMC Dev. Biol. 12, 25.
20. Haldimann, M., Custer, D., Munarini, N., Stirnimann, C., Zurcher, G., Rohrbach, V., Djonov, V., Ziemiecki, A. & Andres, A.C. 2009. Deregulated ephrin-B2 expression in the mammary gland interferes with the development of both the glandular epithelium and vasculature and promotes metastasis formation. Int. J. Oncol. 35, 525-536.
21. Harrison, H., Simoes, B. M., Rogerson, L., Howell, S. J., Landberg, G. & Clarke, R. B. 2013. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling. Breast Cancer Res. 15, R21.
22. Haskill, S., Martin, G., Van Le, L., Morris, J., Peace, A., Bigler, C.F., Jaffe, G.J., Hammerberg, C., Sporn, S.A. & Fong, S. 1991. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc. Natl Acad. Sci. USA 88, 3681-3685.
23. Hatsell, S., Rowlands, T., Hiremath, M. & Cowin, P. 2003. Beta-catenin and Tcfs in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 8, 145-158.
24. Heroult, M., Schaffner, F., Pfaff, D., Prahst, C., Kirmse, R., Kutschera, S., Riedel, M., Ludwig, T., Vajkoczy, P., Graeser, R. & Augustin, H.G. 2010. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2. Mol. Cancer Res. 8, 1297-1309.
25. Howe, L. R. & Brown, A. M. 2004. Wnt signaling and breast cancer. Cancer Biol. Ther. 3, 36-41.
26. Huang, J., Xiao, D., Li, G., Ma, J., Chen, P., Yuan, W., Hou, F., Ge, J., Zhong, M., Tang, Y., Xia, X. & Chen, Z. 2013. EphA2 promotes epithelial-mesenchymal transition through the Wnt/beta-catenin pathway in gastric cancer cells. Oncogene doi: 10.1038/onc.2013.238. [Epub ahead of print].
27. Huynh-Do, U., Stein, E., Lane, A. A., Liu, H., Cerretti, D. P. & Daniel, T. O. 1999. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J. 18, 2165-2173.
28. Huynh-Do, U., Vindis, C., Liu, H., Cerretti, D.P., McGrew, J.T., Enriquez, M., Chen, J. & Daniel, T.O. 2002. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 115, 3073-3081.
29. Ingman, W. V., Wyckoff, J., Gouon-Evans, V., Condeelis, J. & Pollard, J. W. 2006. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222-3229.
30. Jarde, T. & Dale, T. 2012. Wnt signalling in murine postnatal mammary gland development. Acta Physiol. 204, 118-127.
31. Kaenel, P., Antonijevic, M., Richter, S., Kuchler, S., Sutter, N., Wotzkow, C., Strange, R. & Andres, A.C. 2012. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway. Int. J. Oncol. 40, 357-369.
32. Kaenel, P., Schwab, C., Mulchi, K., Wotzkow, C. & Andres, A. C. 2011. Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression. Int. J. Oncol. 38, 151-160.
33. Keating, D. T., Sadlier, D. M., Patricelli, A., Smith, S.M., Walls, D., Egan, J.J. & Doran, P.P. 2006. Microarray identifies ADAM family members as key responders to TGF-beta1 in alveolar epithelial cells. Respir. Res. 7, 114.
34. Kim, J., Villadsen, R., Sorlie, T., Fogh, L., Gronlund, S.Z., Fridriksdottir, A.J., Kuhn, I., Rank, F., Wielenga, V.T., Solvang, H., Edwards, P.A., Borresen-Dale, A.L., Ronnov-Jessen, L., Bissell, M.J. & Petersen, O.W. 2012. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc. Natl Acad. Sci. USA 109, 6124-6129.
35. Kobayashi, S., Sugiura, H., Ando, Y., Shiraki, N., Yanagi, T., Yamashita, H. & Toyama, T. 2012. Reproductive history and breast cancer risk. Breast Cancer 19, 302-308.
36. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K. & Quaranta, V. 2000. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148, 615-624.
37. LaMarca, H. L., Visbal, A. P., Creighton, C. J., Liu, H., Zhang, Y., Behbod, F. & Rosen, J.M., 2010. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells 28, 535-544.
38. Lo, A. T., Mori, H., Mott, J. & Bissell, M. J. 2012. Constructing three-dimensional models to study mammary gland branching morphogenesis and functional differentiation. J. Mammary Gland Biol. 17, 103-110.
39. Luetteke, N. C., Qiu, T. H., Fenton, S. E., Troyer, K.L., Riedel, R.F., Chang, A. & Lee, D.C. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739-2750.
40. Mallepell, S., Krust, A., Chambon, P. & Brisken, C. 2006. Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. USA 103, 2196-2201.
41. Martin, T. J., Allan, E. H., Ho, P. W., Gooi, J.H., Quinn, J.M., Gillespie, M.T., Krasnoperov, V. & Sims, N.A. 2010. Communication between ephrinB2 and EphB4 within the osteoblast lineage. Adv. Exp. Med. Biol. 658, 51-60.
42. Miao, H., Strebhardt, K., Pasquale, E. B., Shen, T. L., Guan, J. L. & Wang, B. 2005. Inhibition of integrin-mediated cell adhesion but not directional cell migration requires catalytic activity of EphB3 receptor tyrosine kinase. Role of Rho family small GTPases. J. Biol. Chem. 280, 923-932.
43. Mori, H., Lo, A. T., Inman, J. L., Alcaraz, J., Ghajar, C.M., Mott, J.D., Nelson, C.M., Chen, C.S., Zhang, H., Bascom, J.L., Seiki, M. & Bissell, M.J. 2013. Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin beta1. Development 140, 343-352.
44. Munarini, N., Jager, R., Abderhalden, S., Zuercher, G., Rohrbach, V., Loercher, S., Pfanner-Meyer, B., Andres, A.C. & Ziemiecki, A. 2002. Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J. Cell Sci. 115, 25-37.
45. Nguyen-Ngoc, K. V. & Ewald, A. J. 2013. Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix. J. Microsc. 251, 212-23.
46. Nieman, K. M., Romero, I. L., Van Houten, B. & Lengyel, E. 2013. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Acta 1831, 1533-41.
47. Nikolova, Z., Djonov, V., Zuercher, G., Andres, A. C. & Ziemiecki, A. 1998. Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J. Cell Sci. 111(Pt 18), 2741-2751.
48. Noren, N. K., Lu, M., Freeman, A. L., Koolpe, M. & Pasquale, E. B. 2004. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc. Natl Acad. Sci. USA 101, 5583-5588.
49. Noren, N. K. & Pasquale, E. B. 2007. Paradoxes of the EphB4 receptor in cancer. Cancer Res. 67, 3994-3997.
50. Ohno, S. 2001. Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity. Curr. Opin. Cell Biol. 13, 641-648.
51. Parashurama, N., Lobo, N. A., Ito, K., Mosley, A.R., Habte, F.G., Zabala, M., Smith, B.R., Lam, J., Weissman, I.L., Clarke, M.F. & Gambhir, S.S 2012. Remodeling of endogenous mammary epithelium by breast cancer stem cells. Stem Cells 30, 2114-2127.
52. Parsa, S., Ramasamy, S. K., De Langhe, S., Gupte, V.V., Haigh, J.J., Medina, D. & Bellusci, S. 2008. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev. Biol. 317, 121-131.
53. Pasquale, E. B. 2010. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180.
54. Polyak, K. & Kalluri, R. 2010. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb. Perspect. Biol. 2, a003244.
55. Pond, A. C., Bin, X., Batts, T., Roarty, K., Hilsenbeck, S. & Rosen, J. M. 2013. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells 31, 178-189.
56. Popnikolov, N. K., Cavone, S. M., Schultz, P. M. & Garcia, F. U. 2005. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells. Mod. Pathol. 18, 1535-1541.
57. Sawamiphak, S., Seidel, S., Essmann, C. L., Wilkinson, G.A., Pitulescu, M.E., Acker, T. & Acker-Palmer, A. 2010. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465, 487-491.
58. Scherberich, A., Tucker, R. P., Degen, M., Brown-Luedi, M., Andres, A. C. & Chiquet-Ehrismann, R. 2005. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 24, 1525-1532.
59. Schmitt, F., Nguyen, P. H., Gupta, N. & Mayer, D. 2013. Eph receptor B4 is a regulator of estrogen receptor alpha in breast cancer cells. J. Recept. Signal Transduct. Res. 33, 244-8.
60. Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G.K., Asselin-Labat, M.L., Wu, L., Lindeman, G.J. & Visvader, J.E. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88.
61. Shekhar, M. P., Werdell, J. & Tait, L. 2000. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res. 60, 439-449.
62. Siar, C. H., Nagatsuka, H., Han, P. P., Buery, R.R., Tsujigiwa, H., Nakano, K., Ng, K.H. & Kawakami, T. 2012. Differential expression of canonical and non-canonical Wnt ligands in ameloblastoma. J. Oral Pathol. Med. 41, 332-339.
63. Smalley, M. J., Kendrick, H., Sheridan, J. M., Regan, J.L., Prater, M.D., Lindeman, G.J., Watson, C.J., Visvader, J.E. & Stingl, J. 2012. Isolation of mouse mammary epithelial subpopulations: a comparison of leading methods. J. Mammary Gland Biol. Neoplasia 17, 91-97.
64. Solanas, G., Cortina, C., Sevillano, M. & Batlle, E. 2011. Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat. Cell Biol. 13, 1100-1107.
65. Spicer, A. P., Rowse, G. J., Lidner, T. K. & Gendler, S. J. 1995. Delayed mammary tumor progression in Muc-1 null mice. J. Biol. Chem. 270, 30093-30101.
66. Stahl, S., Weitzman, S. & Jones, J. C. 1997. The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J. Cell Sci. 110(Pt 1), 55-63.
67. Sternlicht, M. D. 2006. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 8, 201.
68. Sternlicht, M. D., Sunnarborg, S. W., Kouros-Mehr, H., Yu, Y., Lee, D. C. & Werb, Z. 2005. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132, 3923-3933.
69. Stingl, J. 2009. Detection and analysis of mammary gland stem cells. J. Pathol. 217, 229-241.
70. Stingl, J., Eirew, P., Ricketson, I., Shackleton, M., Vaillant, F., Choi, D., Li, H.I. & Eaves, C.J. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439, 993-997.
71. Suzuki, A. & Ohno, S. 2006. The PAR-aPKC system: lessons in polarity. J. Cell Sci. 119, 979-987.
72. Vafaizadeh, V., Klemmt, P., Brendel, C., Weber, K., Doebele, C., Britt, K., Grez, M., Fehse, B., Desrivieres, S. & Groner, B. 2010. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. Stem Cells 28, 928-938.
73. Vazquez, F., Hastings, G., Ortega, M. A., Lane, T.F., Oikemus, S., Lombardo, M. & Iruela-Arispe, M.L. 1999. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity. J. Biol. Chem. 274, 23349-23357.
74. Visvader, J. E. & Smith, G. H. 2011. Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb. Perspect. Biol. 3.
75. Wiseman, B. S. & Werb, Z. 2002. Stromal effects on mammary gland development and breast cancer. Science 296, 1046-1049.
76. Xu, Y., Zagoura, D., Keck, C. & Pietrowski, D. 2006. Expression of Eph receptor tyrosine kinases and their ligands in human Granulosa lutein cells and human umbilical vein endothelial cells. Exp Clin Endocrinol Diabetes 114, 590-595.
77. Zhang, J. & Hughes, S. 2006. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J. Pathol. 208, 453-461.
78. Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T. & Matsuo, K 2006. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 4, 111-121.